Use Alkermes to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
1 Month Beta ..........
1.6
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Alkermes will likely underperform.
The median price of Alkermes for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 17.79 with a coefficient of variation of 4.96. The daily time series for the period is distributed with a sample standard deviation of 0.86, arithmetic mean of 17.4, and mean deviation of 0.74. The Stock received some media coverage during the period.
Alkermes Inc. [ALKS] is traded on American Stock Exchange in USA. It is located in Dublin, and employs 600 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.08 B. Alkermes Inc. conducts business under Healthcare sector and is part of Drug Delivery industry. This company has 130.24 M outstanding shares of which 6.94 M shares are presently shorted by private and institutional investors with about 7.2 trading days to cover.
Alkermes Liquidity
ALKERMES INC currently holds about 190.45 M in cash with (2.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
The company currently holds 444.46 M in liabilities with Debt to Equity (D/E) ratio of 0.52 which is about averege as compared to similar companies. Alkermes Inc. has Current Ratio of 3.72 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
AMEX
